Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Nerve Conduction Study for Assessment of Peripheral Neuropathy in Rheumatoid Arthritis Patients on the Janus Kinase Inhibitor Baricitinib [NA]

View source ↗

Summary

This clinical trial update describes a nerve conduction study to assess peripheral neuropathy in rheumatoid arthritis patients treated with baricitinib (a JAK i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baricitinib (baricitinib)

Snippet

Sponsor: Sohag University | Conditions: Rheumatoid Arthritis | NA | Status: NOT_YET_RECRUITING